Vadastuximab
Vadastuximab (Anti-Human CD33 Recombinant Antibody) is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine[1].
Product Specifications
CAS Number
[1436390-63-4]
Product Name Alternative
Anti-Human CD33 Recombinant Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vadastuximab.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Vadastuximab]
Molecular Weight
(144.78 kDa)
References & Citations
[1]Eytan M Stein, et al. A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia. Blood. 2018 Jan 25;131 (4) :387-396.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1056896-01 0.02 mg (E-Coli)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details 
MBS1056896-02 0.1 mg (E-Coli)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details 
MBS1056896-03 0.02 mg (Yeast)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details MBS1056896-04 0.1 mg (Yeast)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details 
MBS1056896-05 0.02 mg (Baculovirus)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details MBS1056896-06 1 mg (E-Coli)
Recombinant Hordeum vulgare Non-specific lipid-transfer protein 1 (LTP1)
Ask
View Details